Cutaneous manifestations secondary to panitumumab therapy

Clin Dermatol. 2021 Sep-Oct;39(5):887-889. doi: 10.1016/j.clindermatol.2021.07.014. Epub 2021 Aug 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal* / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Panitumumab / adverse effects
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / drug therapy

Substances

  • Antibodies, Monoclonal
  • Panitumumab